These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25147601)

  • 1. Repurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents.
    Mandapati K; Gorla SK; House AL; McKenney ES; Zhang M; Rao SN; Gollapalli DR; Mann BJ; Goldberg JB; Cuny GD; Glomski IJ; Hedstrom L
    ACS Med Chem Lett; 2014 Aug; 5(8):846-50. PubMed ID: 25147601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
    Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
    J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.
    Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR
    Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
    Gorla SK; Kavitha M; Zhang M; Chin JE; Liu X; Striepen B; Makowska-Grzyska M; Kim Y; Joachimiak A; Hedstrom L; Cuny GD
    J Med Chem; 2013 May; 56(10):4028-43. PubMed ID: 23668331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacillus anthracis inosine 5'-monophosphate dehydrogenase in action: the first bacterial series of structures of phosphate ion-, substrate-, and product-bound complexes.
    Makowska-Grzyska M; Kim Y; Wu R; Wilton R; Gollapalli DR; Wang XK; Zhang R; Jedrzejczak R; Mack JC; Maltseva N; Mulligan R; Binkowski TA; Gornicki P; Kuhn ML; Anderson WF; Hedstrom L; Joachimiak A
    Biochemistry; 2012 Aug; 51(31):6148-63. PubMed ID: 22788966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.
    Sarwono AEY; Mitsuhashi S; Kabir MHB; Shigetomi K; Okada T; Ohsaka F; Otsuguro S; Maenaka K; Igarashi M; Kato K; Ubukata M
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):171-178. PubMed ID: 30451014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for
    Modi G; Marqus GM; Vippila MR; Gollapalli DR; Kim Y; Manna AC; Chacko S; Maltseva N; Wang X; Cullinane RT; Zhang Y; Kotler JLM; Kuzmic P; Zhang M; Lawson AP; Joachimiak A; Cheung A; Snider BB; Rothstein DM; Cuny GD; Hedstrom L
    ACS Infect Dis; 2021 Nov; 7(11):3062-3076. PubMed ID: 34590817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.
    Kirubakaran S; Gorla SK; Sharling L; Zhang M; Liu X; Ray SS; Macpherson IS; Striepen B; Hedstrom L; Cuny GD
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1985-8. PubMed ID: 22310229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Lee S; Ku AF; Vippila MR; Wang Y; Zhang M; Wang X; Hedstrom L; Cuny GD
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127543. PubMed ID: 32931912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
    Gorla SK; Kavitha M; Zhang M; Liu X; Sharling L; Gollapalli DR; Striepen B; Hedstrom L; Cuny GD
    J Med Chem; 2012 Sep; 55(17):7759-71. PubMed ID: 22950983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase (CpIMPDH) inhibitors.
    Sun Z; Khan J; Makowska-Grzyska M; Zhang M; Cho JH; Suebsuwong C; Vo P; Gollapalli DR; Kim Y; Joachimiak A; Hedstrom L; Cuny GD
    J Med Chem; 2014 Dec; 57(24):10544-50. PubMed ID: 25474504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.
    Johnson CR; Gorla SK; Kavitha M; Zhang M; Liu X; Striepen B; Mead JR; Cuny GD; Hedstrom L
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1004-7. PubMed ID: 23324406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
    Maurya SK; Gollapalli DR; Kirubakaran S; Zhang M; Johnson CR; Benjamin NN; Hedstrom L; Cuny GD
    J Med Chem; 2009 Aug; 52(15):4623-30. PubMed ID: 19624136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of Cryptosporidium IMP dehydrogenase bound to an inhibitor with in vivo antiparasitic activity.
    Kim Y; Makowska-Grzyska M; Gorla SK; Gollapalli DR; Cuny GD; Joachimiak A; Hedstrom L
    Acta Crystallogr F Struct Biol Commun; 2015 May; 71(Pt 5):531-8. PubMed ID: 25945705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of inosine 5'-monophosphate dehydrogenase as emerging new generation antimicrobial agents.
    Juvale K; Shaik A; Kirubakaran S
    Medchemcomm; 2019 Aug; 10(8):1290-1301. PubMed ID: 31534651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents.
    Fotie J
    Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR and deep learning model for virtual screening of potential inhibitors against Inosine 5' Monophosphate dehydrogenase (IMPDH) of Cryptosporidium parvum.
    Asmare MM; Nitin N; Yun SI; Mahapatra RK
    J Mol Graph Model; 2022 Mar; 111():108108. PubMed ID: 34911011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors.
    Sahu NU; Purushothaman G; Thiruvenkatam V; Kharkar PS
    Drug Dev Res; 2019 Feb; 80(1):125-132. PubMed ID: 30381846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Inosine-5'-monophosphate Dehydrogenase from Bacillus anthracis: Mechanism Revealed by Pre-Steady-State Kinetics.
    Wei Y; Kuzmič P; Yu R; Modi G; Hedstrom L
    Biochemistry; 2016 Sep; 55(37):5279-88. PubMed ID: 27541177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
    Shah CP; Kharkar PS
    Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.